Insulet stock holds at USD 140.53 near its yearly low
Published on 09/22/2026 at 18:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Insulet Corporation (ISIN US45784P1012) opened at USD 140.53 on Nasdaq on September 22, 2026, near the lower end of its 52-week range. The stock's market capitalization stood at USD 9.75 billion, giving investors a clear measure of how far the valuation has contracted from its yearly high.
Stock remains near yearly low
MarketBeat reported on September 22, 2026, that Insulet shares opened at USD 140.53 on Nasdaq. The same market snapshot placed the 52-week range at USD 126.40 to USD 354.88 and the market capitalization at USD 9.75 billion, while the P/E ratio was 26.27.
The gap between the opening price and the 52-week high is substantial: USD 214.35, or about 60.4 percent below the upper end of the range. At the same time, the stock was only USD 14.13, or about 11.2 percent, above the 52-week low. That contrast makes valuation and execution more important than broad index strength for the company.
Revenue grows in Q2 2026
According to Yahoo Finance on September 21, 2026, Insulet reported revenue of USD 801.7 million in the second quarter of 2026, an increase of 23.5 percent from the prior year. Revenue also exceeded analysts' expectations by 1.9 percent.
The quarterly result provides a quantified counterweight to the weak share-price position: revenue growth was 23.5 percent year over year, while the stock was reported at USD 140.64 on September 21, 2026, down 15.7 percent since the results. Yahoo Finance also said that Insulet beat EPS expectations, but its next-quarter revenue guidance missed analysts' expectations, creating a clear tension between reported growth and forward execution.
Valuation depends on execution
Yahoo Finance described Insulet's tubeless Pod technology and Omnipod product line as the company's core diabetes-care business in its September 21, 2026 report. The combination of 23.5 percent quarterly revenue growth and guidance below expectations leaves the forward outlook as the main variable behind the depressed share price.
MarketBeat's September 22, 2026 snapshot recorded a P/E ratio of 26.27 and a PEG ratio of 1.11. Those figures put the market's assessment alongside the operating comparison: investors are paying a meaningful earnings multiple while demanding that the company convert strong current revenue growth into more reliable future guidance.
Insulet stock closes below its high
Insulet stock last closed at USD 140.60 on Nasdaq on September 18, 2026, according to the dated market report. The September 22 opening price of USD 140.53, the USD 9.75 billion market capitalization and the USD 126.40 to USD 354.88 52-week range frame the current trading picture.
Insulet Corporation stock data
- Company: Insulet Corporation
- ISIN: US45784P1012
- Ticker: PODD
- Trading venue: Nasdaq
- Price as of September 22, 2026: USD 140.53
- Market capitalization: USD 9.75 billion (as of September 22, 2026)
- Sector / Industry: Healthcare / Medical devices
